Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

J&J Names Top Executive to Lead China Operations

publication date: Aug 29, 2013
View a Printer Friendly version of this page, allowing you to print the page.
Johnson & Johnson has emphasized the importance of China by restructuring its China operations and putting a single high-powered executive in charge of all three of its China business segments (pharmaceuticals, medical devices/diagnostics and consumer healthcare). To show that it is serious about China, J&J selected Jesse Wu, who had been Global Head of Consumer Healthcare for the company, to oversee its China operations. Mr. Wu’s Consumer Healthcare division generated $14.4 billion of revenue for J&J last year, while China was responsible for a much smaller $2.5 billion of the company’s sales. Apparently, J&J wants to make sure its China operations are fully optimized. More details....

Stock Symbol: (NYSE: JNJ)

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China